Kessel D, Garbo G M, Hampton J
Department of Pharmacology, Wayne State University School of Medicine, Detroit, MI 48201.
Photochem Photobiol. 1993 Feb;57(2):298-301. doi: 10.1111/j.1751-1097.1993.tb02290.x.
The role of plasma lipoproteins in the distribution of the photosensitizing agent tin etiopurpurin (SnET2) was examined in male rats bearing the N-[4-(5-nitro-2-furyl)-2- thiazolyl1bdformamide-induced tumor. Treatment with 17 alpha-ethinyl estradiol resulted in the depletion of total plasma cholesterol by > 70% and a corresponding decrease in plasma lipoproteins. To both control and estradiol-treated animals, a therapeutic dose (1.5 mg/kg) of SnET2 was administered and biodistribution measured 24 h later. Estradiol treatment was not associated with differences in the distribution of SnET2 to liver, skin or tumor, or in the pattern of affinity of SnET2 to plasma albumin and lipoprotein. These results indicate that a substantial decrease in circulating lipoprotein levels does not alter patterns of SnET2 biodistribution.
在携带N-[4-(5-硝基-2-呋喃基)-2-噻唑基]甲酰胺诱导肿瘤的雄性大鼠中,研究了血浆脂蛋白在光敏剂替普卟啉锡(SnET2)分布中的作用。用17α-乙炔雌二醇治疗导致血浆总胆固醇减少>70%,血浆脂蛋白相应减少。给对照动物和经雌二醇治疗的动物均给予治疗剂量(1.5mg/kg)的SnET2,并在24小时后测量生物分布。雌二醇治疗与SnET2在肝脏、皮肤或肿瘤中的分布差异无关,也与SnET2与血浆白蛋白和脂蛋白的亲和模式差异无关。这些结果表明,循环脂蛋白水平的大幅降低不会改变SnET2的生物分布模式。